Related topics:
Food And Drug stories:
Pfizer's Geodon gets expanded FDA approval
Nov 20th, 2009 - Forbes
NEW YORK -- Pfizer Inc. said Friday the Food and Drug Administration approved Geodon as a part of a combination maintenance treatment for bipolar disorder in adults. The new approval covers use of Geodon as an adjunct to lithium or valproate.
Dendreon's potential prostate cancer treatment Provenge gets May 1 FDA review date
Nov 20th, 2009 - ChicagoTribune
SEATTLE (AP) - Biotechnology company Dendreon Corp. said Friday the Food and Drug Administration will make a regulatory decision on the potential prostate cancer vaccine Provenge by May 1. The drug is aimed at treating prostate cancer...
Antigenics pulls European Oncophage application
Nov 20th, 2009 - Boston
LEXINGTON - Biotechnology company Antigenics Inc. said today it will not seek approval for a potential kidney cancer treatment after a European advisory committee recommended against approving the drug candidate.
UPDATE 1-Covidien says FDA extends review of opiod pain drug
Nov 20th, 2009 - Reuters
* FDA sets Feb. 22, 2010, as new action date * Says FDA needs more time to review additional data Nov 20 (Reuters) - Covidien Plc (COV.N) said U.S. healthregulators extended...
FDA advisory panel backs safety of Spiriva Handihaler
Nov 20th, 2009 - Dispatch
WASHINGTON -- Federal health experts yesterday brushed off lingering safety questions about apopular inhaler drug and suggested that it carry bolder benefit claims. The...



